The original version of Freenome's blood-based SimpleScreen CRC screening test is already FDA-approved for colorectal cancer surveillance.

Cancer treatment, oncology drug access, hematologic malignancies, and cancer drug policy.

Bryan Johnson, rapamycin, NAD+, cellular reprogramming, biological age tests, peptides, and emerging longevity interventions.

Specific solid tumor cancer types organized by organ system and tissue origin.

Cancer prevention strategies, screening, early detection, and diagnostic approaches.